Table 1.
Patient characteristics (n = 31)
| Characteristic | Value |
|---|---|
| Male sex | 27 (87.1) |
| Age, yr | 64.4 ± 7.1 |
| Performance status | |
| 0 | 6 (19.4) |
| 1 | 25 (80.6) |
| Smoking status | |
| Never-smoker | 5 (16.1) |
| Former-smoker | 14 (45.2) |
| Current-smoker | 12 (38.7) |
| Pathology | |
| Squamous cell | 20 (64.5) |
| Adenocarcinoma | 10 (32.3) |
| Large cell | 1 (3.2) |
| Histologic differentiation | |
| Moderate | 20 (64.5) |
| Poor | 11 (35.5) |
| Stage | |
| IIB | 3 (9.7) |
| IIIA | 21 (67.7) |
| IIIB | 7 (22.6) |
| Regimen | |
| Docetaxel-cisplatin | 28 (90.3) |
| Docetaxel-carboplatin | 3 (9.7) |
| No. of IC cycles | |
| 2 | 15 (48.4) |
| 3 | 15 (48.4) |
| 4 | 1 (3.2) |
| RDI | 89.4 ± 11.7 |
Values are presented as number (%) or mean ± SD.
IC, induction chemotherapy; RDI, relative dose intensity.